Chenodal (Retrophin, Inc.)
Welcome to the PulseAid listing for the Chenodal drug offered from Retrophin, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Retrophin, Inc. |
NON-PROPRIETARY NAME: | Chenodiol |
SUBSTANCE NAME: | CHENODIOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-12-28 |
END MARKETING DATE: | 0000-00-00 |
Chenodal HUMAN PRESCRIPTION DRUG Details:
Item Description | Chenodal from Retrophin, Inc. |
LABELER NAME: | Retrophin, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2015-12-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68974-876_277566fc-6896-45e7-913d-b7a74291f07f |
PRODUCT NDC: | 68974-876 |
APPLICATION NUMBER: | ANDA091019 |
Other CHENODIOL Pharmaceutical Manufacturers / Labelers: